[Panotile in ear surgery].
D000287:Administration, Topical; D000891:Anti-Infective Agents, Local / Q000009:adverse effects / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001548:Benzalkonium Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004432:Ear, Middle / Q000601:surgery*; D005438:Fludrocortisone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D009355:Neomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010031:Otitis / Q000188:drug therapy; D011112:Polymyxin B / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011113:Polymyxins / Q000627:therapeutic use*; D011182:Postoperative Care
D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D001548:Benzalkonium Compounds; D004338:Drug Combinations; D011113:Polymyxins; D009355:Neomycin; D011112:Polymyxin B; D005438:Fludrocortisone
Le panotile en chirurgie otologique.